https://www.selleckchem.com/pr....oducts/CP-690550.htm
19, 95% confidence interval = 1.21-4.36, p = 0.01). The present study suggests that aberrant methylation of SLIT2 in plasma cell-free DNA is a valuable biomarker for the early detection of NSCLC and prediction of recurrence-free survival. However, further research is needed with larger sample size to confirm results.The interest in using targeted radiopharmaceuticals in nuclear oncology has increased in recent years and continues to grow [...].Mutations and loss of E-cadherin protein expression define the vast majority of invasive lob
Like
Comment
Share
